GBA1 and Parkinson disease: Mutations in GBA present a wide spectrum of clinical manifestations [77]; homozygous and heterozygous mutations in GBA numerically constitute the most prominent risk factor for Parkinson’s disease (PD), and homozygous mutations in GBA result in GlcCer accumulation, leading to GD pathology.